Generate Investment Management Ltd Invests $8.04 Million in Danaher Co. (NYSE:DHR)

Generate Investment Management Ltd acquired a new stake in Danaher Co. (NYSE:DHR) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 35,043 shares of the conglomerate’s stock, valued at approximately $8,044,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in DHR. Heck Capital Advisors LLC acquired a new position in Danaher during the fourth quarter worth $27,000. Decker Retirement Planning Inc. purchased a new stake in shares of Danaher during the 4th quarter worth $31,000. Golden State Wealth Management LLC acquired a new position in shares of Danaher during the 4th quarter worth $31,000. Teachers Insurance & Annuity Association of America purchased a new position in shares of Danaher in the 3rd quarter valued at about $39,000. Finally, MidAtlantic Capital Management Inc. acquired a new stake in shares of Danaher in the third quarter valued at about $40,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

DHR has been the topic of several recent analyst reports. Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a research report on Thursday, October 31st. KeyCorp raised their price objective on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Stephens reiterated an “overweight” rating and set a $315.00 target price on shares of Danaher in a research report on Wednesday, October 23rd. Citigroup dropped their price target on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research report on Thursday, January 30th. Finally, Wells Fargo & Company decreased their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Danaher Price Performance

Shares of NYSE:DHR opened at $206.92 on Friday. The business has a fifty day simple moving average of $233.38 and a 200-day simple moving average of $252.10. Danaher Co. has a 52 week low of $205.79 and a 52 week high of $281.70. The company has a market cap of $149.45 billion, a P/E ratio of 39.19, a P/E/G ratio of 2.80 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the prior year, the company posted $2.09 earnings per share. Equities research analysts forecast that Danaher Co. will post 7.77 EPS for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.52%. Danaher’s dividend payout ratio (DPR) is presently 20.45%.

Insider Activity

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 10.90% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.